Business Standard

Wednesday, December 25, 2024 | 01:06 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Dr Reddy's falls 3%, hits 52-week low; stock slips 10% in one month

The stock of the pharmaceutical company, which has a significant presence in the Russian market, has fallen below its previous low of Rs 4,135.90 touched on March 19, 2021

DRDO’s 2DG anti-Covid drug priced at Rs 990 per sachet: Dr Reddy's
Premium

SI Reporter Mumbai
Shares of Dr Reddy's Laboratories hit a 52-week low of Rs 4,055.85, down 3 per cent on the BSE in Thursday's intra-day trade, after Russia ordered military operations in Ukraine and reports emerged of blasts in some major Ukrainian cities.

The stock of the pharmaceutical company, which has a significant presence in the Russian market, has fallen below its previous low of Rs 4,135.90 touched on March 19, 2021. In the past one month, it has underperformed the market by falling 10 per cent as compared to 5 per cent decline in the S&P BSE Sensex.

According to

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in